Answer
Acipimox inhibits fatty acid release from adipose tissue and reduces blood VLDL and LDL concentrations, lowering triglyceride and cholesterol levels; it also increases HDL during treatment.
Sources for this answer
- Olbetam Capsules 250Pfizer Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 12Document updated
Sources checked